IN-DATE
50-7262: BD PleurX Supplemental Insertion Kit
Sign in to add this product to your favorites!
| Price: | $5.65 EACH |
|---|---|
| Quantity: | |
| In Stock: | 4 eaches |
| Status: | expired |
Additional Details
BD PleurX Supplemental Insertion Kit
The supplemental insertion kit aids percutaneous insertion of the PleurX catheter into the pleural or peritoneal space. The orange stylet occludes the fenestrations in the catheter, helping reduce the amount of fluid leakage during catheter placement. The stylet also makes the catheter more rigid for ease of insertion into the valved introducer. The valved introducer helps reduce air entering into and fluid leaking from the pleural or peritoneal space.
Product Code: 50-7262
- Catheter insertion stylet
- Valved peel-away introducer
AccessGUDID Info
- FDA Product Code: PNG
- FDA Product Code Name: Peritoneal, drainage catheter for refractory ascites, long-term indwelling
- FDA Product Code: DWM
- FDA Product Code Name: Apparatus, Suction, Patient Care
- GMDN Term Code: 62391
- GMDN Term Name: Non-vascular catheter introduction set
- GMDN Term Description: A collection of invasive devices intended to enable percutaneous Seldinger-type introduction of a non-vascular catheter (e.g., drainage catheter) into a body cavity or lumen (e.g., biliary tract, ureter); it is not intended for introduction of a peritoneal dialysis catheter. It includes multiple invasive access devices which typically include an introducer needle, introducer sheath with an inner dilator, and guidewire; the catheter is not included. This is a single-use device.
Manufacturer
Becton, Dickinson and Company (BD) is a global medical technology leader providing a broad range of products across medication management, diagnostics, and surgical care. BD’s Medical segment includes industry-leading solutions in medication delivery, such as BD syringes, needles, and infusion systems, as well as devices for diabetes care and pharmaceutical pre-fillable systems. The Life Sciences division supports clinical diagnostics and research with products like BD Vacutainer blood collection systems and BD Veritor rapid testing platforms. BD’s Interventional segment includes advanced surgical products from acquired brands like Bard and Tepha, with specialties in infection prevention, hernia repair, biosurgery, and urology. With a focus on advancing health through technology, BD supports hospitals, labs, and clinicians worldwide in improving safety, efficiency, and patient outcomes.
